Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431.
作者信息
Orgel Etan, Villaluna Doojduen, Krailo Mark D, Esbenshade Adam, Sung Lillian, Freyer David R
机构信息
Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA; Department of Pediatrics, University of Southern California, Los Angeles, CA, USA.
Children's Oncology Group, Monrovia, CA, USA.
出版信息
Lancet Oncol. 2022 May;23(5):570-572. doi: 10.1016/S1470-2045(22)00155-3.
Abstract
摘要
相似文献
1
Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431.硫代硫酸钠预防顺铂所致听力损失：来自ACCL0431的最新生存情况
Lancet Oncol. 2022 May;23(5):570-572. doi: 10.1016/S1470-2045(22)00155-3.
2
Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial.硫代硫酸钠与观察对癌症患儿顺铂诱导性听力损失发展的影响（ACCL0431）：一项多中心、随机、对照、开放标签的3期试验
Lancet Oncol. 2017 Jan;18(1):63-74. doi: 10.1016/S1470-2045(16)30625-8. Epub 2016 Dec 1.
3
Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss.硫代硫酸钠预防顺铂所致耳聋的研究
N Engl J Med. 2018 Jun 21;378(25):2376-2385. doi: 10.1056/NEJMoa1801109.
4
Assessment of provider perspectives on otoprotection research for children and adolescents: A Children's Oncology Group Cancer Control and Supportive Care Committee survey.评估医疗服务提供者对儿童和青少年耳毒性保护研究的看法：儿童肿瘤学组癌症控制和支持性护理委员会的调查。
Pediatr Blood Cancer. 2020 Nov;67(11):e28647. doi: 10.1002/pbc.28647. Epub 2020 Sep 4.
5
Prevention of cisplatin-induced hearing-loss by sodium thiosulfate in medulloblastoma.硫代硫酸钠预防髓母细胞瘤中顺铂诱导的听力损失
Pediatr Int. 2020 Oct;62(10):1204-1206. doi: 10.1111/ped.14271. Epub 2020 Sep 29.
6
Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients.一项评估新型鼓室内给予硫代硫酸盐以预防癌症患者顺铂所致听力损失的安全性、耐受性和药代动力学的 1 期研究。
Invest New Drugs. 2020 Oct;38(5):1463-1471. doi: 10.1007/s10637-020-00918-1. Epub 2020 Mar 10.
7
Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline.预防癌症儿童和青少年顺铂诱导的耳毒性：临床实践指南。
Lancet Child Adolesc Health. 2020 Feb;4(2):141-150. doi: 10.1016/S2352-4642(19)30336-0. Epub 2019 Dec 19.
8
Hepatoblastoma, cisplatin, and ototoxicity: good news on deaf ears.肝母细胞瘤、顺铂与耳毒性：对聋耳而言的好消息。
Cancer. 2009 Dec 15;115(24):5623-6. doi: 10.1002/cncr.24668.
9
Use of Sodium Thiosulfate as an Otoprotectant in Patients With Cancer Treated With Platinum Compounds: A Review of the Literature.硫代硫酸钠在铂类化合物治疗的癌症患者中的耳保护作用：文献复习。
J Clin Oncol. 2024 Jun 20;42(18):2219-2232. doi: 10.1200/JCO.23.02353. Epub 2024 Apr 22.
10
A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer.一项随机对照试验，旨在测试经鼓膜注射硫代硫酸钠凝胶预防头颈部癌症患者顺铂诱导耳毒性的疗效。
J Otolaryngol Head Neck Surg. 2019 Jan 16;48(1):4. doi: 10.1186/s40463-019-0327-x.
引用本文的文献
1
Platinum-induced ototoxicity and hearing impairment in children and adolescents.铂诱导的儿童和青少年耳毒性及听力损害。
Drugs Context. 2025 Jun 5;14. doi: 10.7573/dic.2025-3-1. eCollection 2025.
2
Approaches to Reduce Toxicity in Pediatric Brain Tumors.降低小儿脑肿瘤毒性的方法。
Curr Oncol. 2025 May 15;32(5):281. doi: 10.3390/curroncol32050281.
3
Advancing medulloblastoma therapy: strategies and survival insights.髓母细胞瘤治疗进展：策略与生存见解
Clin Exp Med. 2025 Apr 16;25(1):119. doi: 10.1007/s10238-025-01648-5.
4
Cisplatin-Induced Hearing Loss, Oxidative Stress, and Antioxidants as a Therapeutic Strategy-A State-of-the-Art Review.顺铂诱导的听力损失、氧化应激与抗氧化剂作为一种治疗策略——最新综述
Antioxidants (Basel). 2024 Dec 21;13(12):1578. doi: 10.3390/antiox13121578.
5
Otoprotective Effects of Sodium Thiosulfate by Demographic and Clinical Characteristics: A Report From Children's Oncology Group Study ACCL0431.硫代硫酸钠按人口统计学和临床特征分类的耳保护作用：儿童肿瘤学组ACCL0431研究报告
Pediatr Blood Cancer. 2025 Mar;72(3):e31479. doi: 10.1002/pbc.31479. Epub 2024 Dec 9.
6
Modulating the unfolded protein response with ISRIB mitigates cisplatin ototoxicity.用 ISRIB 调节未折叠蛋白反应可减轻顺铂耳毒性。
Sci Rep. 2024 Sep 27;14(1):22382. doi: 10.1038/s41598-024-70561-w.
7
The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma.耳蜗剂量和放疗年龄可预测接受被动散射质子治疗和顺铂化疗的儿童髓母细胞瘤患者发生重度听力损失。
Neuro Oncol. 2024 Oct 3;26(10):1912-1920. doi: 10.1093/neuonc/noae114.
8
Oseltamivir (Tamiflu), a Commonly Prescribed Antiviral Drug, Mitigates Hearing Loss in Mice.常用抗病毒药物奥司他韦（达菲）可减轻小鼠听力损失。
bioRxiv. 2024 May 8:2024.05.06.592815. doi: 10.1101/2024.05.06.592815.
9
Use of Sodium Thiosulfate as an Otoprotectant in Patients With Cancer Treated With Platinum Compounds: A Review of the Literature.硫代硫酸钠在铂类化合物治疗的癌症患者中的耳保护作用：文献复习。
J Clin Oncol. 2024 Jun 20;42(18):2219-2232. doi: 10.1200/JCO.23.02353. Epub 2024 Apr 22.
10
Prevention of cisplatin-induced hearing loss in children: achievements and challenges for evidence-based implementation of sodium Thiosulfate.预防儿童顺铂所致听力损失：硫代硫酸钠循证应用的成果与挑战
Front Oncol. 2024 Mar 18;14:1336714. doi: 10.3389/fonc.2024.1336714. eCollection 2024.
本文引用的文献
1
Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study.儿童、青少年和青年人群中顺铂所致听力损失的流行情况和危险因素：一项多机构北美队列研究。
Lancet Child Adolesc Health. 2021 Apr;5(4):274-283. doi: 10.1016/S2352-4642(21)00020-1. Epub 2021 Feb 12.
2
Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline.预防癌症儿童和青少年顺铂诱导的耳毒性：临床实践指南。
Lancet Child Adolesc Health. 2020 Feb;4(2):141-150. doi: 10.1016/S2352-4642(19)30336-0. Epub 2019 Dec 19.
3
Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss.硫代硫酸钠预防顺铂所致耳聋的研究
N Engl J Med. 2018 Jun 21;378(25):2376-2385. doi: 10.1056/NEJMoa1801109.
4
Prevention of cisplatin-induced hearing loss in children: Informing the design of future clinical trials.预防儿童顺铂所致听力损失：为未来临床试验的设计提供依据。
Cancer Med. 2018 Jul;7(7):2951-2959. doi: 10.1002/cam4.1563. Epub 2018 May 30.
5
Treatment and survival of childhood neuroblastoma: Evidence from a population-based study in the United States.儿童神经母细胞瘤的治疗与生存：来自美国一项基于人群研究的证据。
Pediatr Hematol Oncol. 2017 Aug;34(5):320-330. doi: 10.1080/08880018.2017.1373315. Epub 2017 Oct 17.
6
Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial.硫代硫酸钠与观察对癌症患儿顺铂诱导性听力损失发展的影响（ACCL0431）：一项多中心、随机、对照、开放标签的3期试验
Lancet Oncol. 2017 Jan;18(1):63-74. doi: 10.1016/S1470-2045(16)30625-8. Epub 2016 Dec 1.
7
Metastatic Medulloblastoma in Childhood: Chang's Classification Revisited.儿童转移性髓母细胞瘤：重新审视Chang分类法
Int J Surg Oncol. 2012;2012:245385. doi: 10.1155/2012/245385. Epub 2011 Sep 11.
8
Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.肝母细胞瘤患儿预处理预后因素的预测能力：来自儿童肿瘤协作组的报告
Pediatr Blood Cancer. 2009 Dec;53(6):1016-22. doi: 10.1002/pbc.22088.
9
Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study.儿童癌症5年幸存者的晚期死亡率：来自儿童癌症幸存者研究的总结
J Clin Oncol. 2009 May 10;27(14):2328-38. doi: 10.1200/JCO.2008.21.1425. Epub 2009 Mar 30.
10
Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children's Oncology Group.长期神经母细胞瘤幸存者的听力损失、生活质量和学业问题：来自儿童肿瘤学组的报告。
Pediatrics. 2007 Nov;120(5):e1229-36. doi: 10.1542/peds.2007-0178.
Zotero 插件